SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001384101-22-000058
Filing Date
2022-04-26
Accepted
2022-04-26 16:14:50
Documents
11
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A vcyt-proxy2022xdef14a.htm DEF 14A 819722
2 GRAPHIC checkboxes.jpg GRAPHIC 1237
3 GRAPHIC diversitycharts.jpg GRAPHIC 38338
4 GRAPHIC picture10.jpg GRAPHIC 61649
5 GRAPHIC picture11.jpg GRAPHIC 87132
6 GRAPHIC picture4.jpg GRAPHIC 1434
7 GRAPHIC picture5.jpg GRAPHIC 1072
8 GRAPHIC picture6.jpg GRAPHIC 1517
9 GRAPHIC picture7.jpg GRAPHIC 1764
10 GRAPHIC picture8.jpg GRAPHIC 28448
11 GRAPHIC picture9.jpg GRAPHIC 44806
  Complete submission text file 0001384101-22-000058.txt   1190480
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

IRS No.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36156 | Film No.: 22854493
SIC: 8071 Services-Medical Laboratories